메뉴 건너뛰기




Volumn 5, Issue 1, 2010, Pages 62-74

Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassays

Author keywords

Assay validation; Linear parallel line assay; Mixed model approach; Non linear parallel line assay; Variance component analysis

Indexed keywords

LINEAR PARALLEL-LINE ASSAY; MIXED MODEL APPROACH; MIXED MODELS; NON-LINEAR; VARIANCE COMPONENT ANALYSIS;

EID: 75649098212     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200900146     Document Type: Article
Times cited : (5)

References (9)
  • 1
    • 75649120627 scopus 로고    scopus 로고
    • 〈111〉 Design and Analysis of Biological assays
    • USP 32 - NF 27, 2008, 〈111〉 Design and Analysis of Biological assays.
    • (2008) USP 32 - NF 27
  • 2
    • 75649103070 scopus 로고    scopus 로고
    • European Pharmacopoeia 6.0. 2008; 5.3 Statistical Analysis of Results of Biological Assays and Tests.
    • European Pharmacopoeia 6.0. 2008; 5.3 Statistical Analysis of Results of Biological Assays and Tests.
  • 3
    • 34447508215 scopus 로고    scopus 로고
    • An optimized automated assay for determination of metabolic stability using hepatocytes:Assay validation, variance component analysis and in vivo relevance
    • Jacobson, L., Middelton, B., Holmgren, J., An optimized automated assay for determination of metabolic stability using hepatocytes:Assay validation, variance component analysis and in vivo relevance. Assay Drug Dev. Technol. 2007, 5, 403-415.
    • (2007) Assay Drug Dev. Technol , vol.5 , pp. 403-415
    • Jacobson, L.1    Middelton, B.2    Holmgren, J.3
  • 4
    • 75649115225 scopus 로고    scopus 로고
    • European Pharmacopoeia 6.0; 5.3 Statistical Analysis of Results of Biological Assays and Tests, Chapter 3.2.3 Analysis of variance, p.574
    • European Pharmacopoeia 6.0; 5.3 Statistical Analysis of Results of Biological Assays and Tests, Chapter 3.2.3 "Analysis of variance", p.574
  • 5
    • 29244453207 scopus 로고    scopus 로고
    • Statistics of assay validation in high-throughput cell imaging of nuclear factor kappaB nuclear translocation
    • Morelock, M. M., Hunter, E.A., Moran, T. J., Heynen, S. et al., Statistics of assay validation in high-throughput cell imaging of nuclear factor kappaB nuclear translocation. Assay Drug Dev.Technol. 2005, 3, 483-499.
    • (2005) Assay Drug Dev.Technol , vol.3 , pp. 483-499
    • Morelock, M.M.1    Hunter, E.A.2    Moran, T.J.3    Heynen, S.4
  • 6
    • 0032031482 scopus 로고    scopus 로고
    • Statistical approaches to determine analytical variability and specifications: Applications of experimental design and variance component analysis
    • Tsang, P. K., Larew, J. S., Larew, L. A., Statistical approaches to determine analytical variability and specifications: Applications of experimental design and variance component analysis. J. Pharm. Biomed. Anal. 1998, 16, 1125-1141.
    • (1998) J. Pharm. Biomed. Anal , vol.16 , pp. 1125-1141
    • Tsang, P.K.1    Larew, J.S.2    Larew, L.A.3
  • 7
    • 4043136615 scopus 로고    scopus 로고
    • Reducing bioassay variability by identifying sources of variation and controlling key parameters in assay protocol
    • Ren, S., Frymier, P.D., Reducing bioassay variability by identifying sources of variation and controlling key parameters in assay protocol. Chemosphere 2004, 57, 81-90.
    • (2004) Chemosphere , vol.57 , pp. 81-90
    • Ren, S.1    Frymier, P.D.2
  • 8
    • 38049094621 scopus 로고    scopus 로고
    • A three-stage experimental strategy to evaluate and validate an interpolate IC50 format
    • Rodrigues, D. J., Lyons, R., Laflin, P., Pointon, W. et al., A three-stage experimental strategy to evaluate and validate an interpolate IC50 format. Assay Drug Dev. Technol. 2007, 5, 805-813
    • (2007) Assay Drug Dev. Technol , vol.5 , pp. 805-813
    • Rodrigues, D.J.1    Lyons, R.2    Laflin, P.3    Pointon, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.